{{Primary sources|date=October 2023}} {{Infobox organization | name = International Federation of Pharmaceutical Manufacturers & Associations | abbreviation = IFPMA | image = | image_border = | caption = | formation = 1968 | type = Trade association | headquarters = Geneva, Switzerland | leader_title = President | leader_name = Dr Thomas Schinecker, CEO, Roche Group | key_people = Dr Thomas Schinecker (President) Dr David Reddy (Director General) | num_staff = | budget = | website = https://www.ifpma.org/ }}

The '''International Federation of Pharmaceutical Manufacturers & Associations''' ('''IFPMA''')<ref>{{cite web|url=https://www.geneve-int.ch/international-federation-pharmaceutical-manufacturers-associations-ifpma-1|title=International Federation of Pharmaceutical Manufacturers & Associations - IFPMA| access-date=2 November 2023}}</ref> is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. '''IFPMA''' is based in Geneva and is in official relations with the United Nations<ref>{{cite web|url=https://www.ungeneva.org/en/practical-information/civil-society/ngo-list|title=List of NGOs accredited at the UN Office at Geneva| accessdate=7 December 2022}}</ref> where it contributes industry expertise to global health discussions.

It was formed in 1968 and is based in Geneva, Switzerland.<ref>{{cite web|url=http://www.ifpma.org/about-ifpma/welcome.html|title=About IFPMA| accessdate=11 Jun 2014|archive-url=https://web.archive.org/web/20140626044433/http://www.ifpma.org/about-ifpma/welcome.html|archive-date=26 June 2014|url-status=dead}}</ref>

In 2019, IFPMA released a strengthened code of ethics<ref>{{cite web|url=https://www.ropesgray.com/en/insights/alerts/2019/02/new-international-pharmaceutical-practice-code-tightens-restrictions-on-gifts|title=New International Pharmaceutical Practice Code Tightens Restrictions on Gifts|date=27 February 2019|access-date=30 October 2023|publisher=Ropes & Gray}}</ref> and professional standards.<ref>{{cite web|url=https://pharmaphorum.com/news/industry-and-patient-groups-collaborate-on-new-guidance-for-interaction/|title=Industry and patient groups collaborate on new guidance for interaction| last= Underwood| first= George| date=18 Mar 2020|accessdate=7 December 2022}}</ref> Among the revisions to the code is a prohibition on gifts provided to healthcare professionals.<ref>{{cite web|url=https://www.pharmaceutical-technology.com/features/ifpma-code-of-practice/|title=IFPMA launches new Code of Practice for the pharmaceutical industry|last= Baker| first=Berry| date=20 December 2018|access-date=30 October 2023|publisher=Pharma Technology}}</ref> The code revision has been followed by Ethoscope<ref>{{cite web|url=https://pharmaboardroom.com/articles/ethoscope-biopharma-industry-unveils-novel-platform-to-promote-ethics-business-integrity/|title=Industry and patient groups collaborate on new guidance for interaction|last= Lugogo| first= Mwana| date=24 April 2023|access-date=30 October 2023|publisher=PharmaBoardroom}}</ref> – an open-source, continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments.

The pharmaceutical industry contributes to the Sustainable Development Goals (SDGs), in particular Goal 3 to ensure healthy lives and promote well-being for all at all ages.<ref>{{cite web|url=https://www.un.org/sustainabledevelopment/health/|title=Goal 3: Ensure healthy lives and promote well-being for all at all ages |access-date=30 October 2023|publisher=United Nations}}</ref> Today over 35 IFPMA member companies contribute resources and know-how to SDG initiatives <ref>''Explore Collaborations Global Health Progress'' 2023, https://globalhealthprogress.org/explore-our-collaborations/</ref> partnering with academia, development organizations, NGOs, foundations and other business sectors. There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access.<ref>{{cite web|url=http://globalhealthprogress.org/|title=Global Health Progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the SDGs| date=18 Mar 2022|access-date=7 December 2022}}</ref>

IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage (UHC) targets and contribute to a world where no one is left behind in receiving the healthcare they need.<ref>{{cite web|url=https://www.uhc2030.org/fileadmin/uploads/UHC2030_Private_Sector_Commitments_Statement_April2023.pdf|title=Private Sector Commitments To Universal Health Coverage, UHC2030 Private Sector Constituency 2023 Statement|access-date=30 October 2023|publisher=UHC2030}}</ref> A wide range of stakeholders across the public and private sectors have an opportunity to collaborate more closely to increase affordability of and access to essential medicines, and the low-cost, but highly effective, interventions and screenings.<ref>{{cite web|url=https://fpanalytics.foreignpolicy.com/2023/04/25/the-road-to-2030-ifpma/|title=The Road to 2030: Revitalizing Multi-sectoral Partnerships to Achieve Universal Health Coverage|access-date=30 October 2023|publisher=Foreign Policy Analytics}}</ref>

== Leadership == The President of IFPMA is Dr Thomas Schinecker, CEO, Roche Group. Robert M. Davis, Chairman and CEO of Merck & Co., and Hiroyuki Okuzawa, President and CEO, [https://www.daiichisankyo.com/ Daiichi Sankyo], serve as Vice-Presidents.<ref>{{Cite web |title=Roche CEO named as new president of IFPMA |url=https://www.thepharmaletter.com/roche-ceo-named-as-new-president-of-ifpma |access-date=2024-11-27 |website=www.thepharmaletter.com |language=en}}</ref>

==See also== *Association of the British Pharmaceutical Industry *European Federation of Pharmaceutical Industries and Associations Europe<ref>''EFPIA'', https://www.ifpma.org/members/efpia/</ref> *Interpharma Switzerland<ref>''Interpharma'', https://www.ifpma.org/members/interpharma/</ref> *Innovative Pharmaceutical Association South Africa<ref>''IPASA'', https://www.ifpma.org/members/ipasa/</ref> *The Japan Pharmaceutical Manufacturers Association<ref>''JPMA'', https://www.ifpma.org/members/jpma/</ref> *Les entreprises du médicament France<ref>''LEEM'', https://www.ifpma.org/members/leem/</ref>

==References== {{Reflist}}

==External links== *{{Official website}}

{{Authority control}}

{{DEFAULTSORT:International Federation of Pharmaceutical Manufacturers and Associations}} Category:Pharmacy-related professional associations